Budesonide, USP: The affected lot may contain a glass fragment.
Brand(s)
Last updated
Summary
Product
Budesonide, USP
Issue
Health products - Product safety
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Budesonide, USP |
Budesonide, USP |
N/A |
Active pharmaceutical ingredient |
Budesonide, USP 500 mg bottle |
202323/H |
Issue
The affected lot may contain a glass fragment.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products
Companies
|
Medisca Pharmaceutique Inc. 4509 rue Dobrin, Saint-Laurent, Quebec H4R 2L8 |
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-75787
Get notified
Receive notifications for new and updated recalls and alerts by category.